|Transcript ID (GRCh37/hg19)||ENST00000256078|
|Genomic Coordinates (GRCh37/hg19)||12:25398283-25398285|
|Tumor Type||Primary Site|
KRAS belongs to the RAS family of oncogenes. KRAS mutations have been described in approximately 3–40% gall bladder adenocarcinomas (more often in East Asia). The prognostic and therapeutic implications of KRAS mutations in gall bladder adenocarcinomas continue to be explored.